Sweden· SE-20151024000041
Lymelysal 300 mg Kapsel, hård
A medicinal product containing lymecycline, registered in Sweden by 2care4 Generics ApS.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Lymecycline
- Manufacturer
- 2care4 Generics ApS
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20151024000041
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lymecycline in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandTetralysalInPharm Sp. z o.o.
- IrelandLycimor 300 mg Capsules, HardTeva B.V.
- BelgiumTetralysal 300 mgPI Pharma
- FinlandLymecycline RatiopharmTeva B.V.
- NorwayLymecyclin ActavisActavis Group PTC ehf
- IcelandLymecycline ActavisActavis Group PTC ehf.
- FranceTETRALYSAL 300 mg, géluleGALDERMA INTERNATIONAL
- United KingdomLymecycline 408mg capsulesAlliance Healthcare (Distribution) Ltd
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Cyclopel
- Belgium · Lymecycline (Entsprechend Tetracyclin-Base) Brown & Burk, Lymecycline (Équivalent À Tétracycline Base) Brown & Burk
- Denmark · Lymecyclin " Brown & Burk ", Lymecyclin Actavis
- Finland · Lymecycline Brown & Burk, Lymecycline Ratiopharm
- France · Lymecycline Arrow, Tetralysal
- United Kingdom (Northern Ireland) · Lymecycline, Lymecycline Actavis
- Hungary · Tetralysal
- Ireland · Lycimor, Rimicorim
- Iceland · Lymecycline Actavis
- Malta · Tetralysal
- Norway · Lymecyclin Actavis, Lymecycline Brown & Burk
- Poland · Tetralysal
- Portugal · Limeciclina Atral
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/784336ac-04de-4b3d-a662-b1f0bd8a8976 GET /v1/drugs/784336ac-04de-4b3d-a662-b1f0bd8a8976?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL",
"sPAR",
"PAR"
],
"se_npl_id": "20151024000041",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20151024000041",
"product_doc_link": "https://docetp.mpa.se/LMF/Lymelysal%20capsule%2C%20hard%20ENG%20SmPC_09001bee807a6532.pdf"
}See everything about lymecycline.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.